RECORD-4: Multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Asian versus non-Asian population subanalysis | |
Yang, L.; Alyasova, A.; Ye, D.; Karpenko, A.; Li, H.; Alekseev, B.; Xie, L.; Kurteva, G.; Kowalyszyn, R. D.; Karyakin, O. | |
2015 | |
卷号 | 26 |
会议录 | ANNALS OF ONCOLOGY |
语种 | 英语 |
URL标识 | 查看原文 |
ISSN号 | 0923-7534 |
内容类型 | 会议论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4867448 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Yang, L.,Alyasova, A.,Ye, D.,et al. RECORD-4: Multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Asian versus non-Asian population subanalysis[C]. 见:. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论